Literature DB >> 27231709

α5GABAA receptor deficiency causes autism-like behaviors.

Agnieszka A Zurek1, Stephen W P Kemp1, Zeenia Aga1, Susan Walker2, Marija Milenkovic3, Amy J Ramsey4, Etienne Sibille5, Stephen W Scherer6, Beverley A Orser7.   

Abstract

The prevalence of autism spectrum disorders (ASDs), which affect over 1% of the population, has increased twofold in recent years. Reduced expression of GABAA receptors has been observed in postmortem brain tissue and neuroimaging of individuals with ASDs. We found that deletion of the gene for the α5 subunit of the GABAA receptor caused robust autism-like behaviors in mice, including reduced social contacts and vocalizations. Screening of human exome sequencing data from 396 ASD subjects revealed potential missense mutations in GABRA5 and in RDX, the gene for the α5GABAA receptor-anchoring protein radixin, further supporting a α5GABAA receptor deficiency in ASDs.

Entities:  

Year:  2016        PMID: 27231709      PMCID: PMC4863752          DOI: 10.1002/acn3.303

Source DB:  PubMed          Journal:  Ann Clin Transl Neurol        ISSN: 2328-9503            Impact factor:   4.511


Introduction

Autism spectrum disorders (ASDs) are complex neurodevelopmental conditions that are characterized by impaired social interactions, deficits in communication, repetitive behaviors, and reduced executive function.1 ASDs occur in approximately 1 in every 68 children in the United States and 30% of cases are associated with genetic causes.2, 3, 4 Duplication of the q11.2–13 region on chromosome 15 is the most common duplication copy number variant associated with ASDs. Deletions of this region of the chromosome cause the neurodevelopmental disorders including Angelman syndrome and Prader–Willi syndrome.5, 6 In humans, the q11.2–13 region of chromosome 15 contains genes that encode the α5, β3, and γ3 subunits of the γ‐aminobutyric acid type A (GABAA) receptor, as well as the ubiquitin protein ligase E3a. Several lines of evidence have implicated α5 subunit‐containing GABAA receptors in ASDs. Postmortem analyses of brain tissue of individuals with ASDs have revealed reduced levels of both mRNA and protein for several GABAA receptor subtypes including α5 and β3 subunits.7, 8, 9 Positron emission tomography studies have shown reduced binding of an α5GABAA receptor‐selective ligand in the amygdala and nucleus accumbens, brain regions that mediate social interaction and reward behaviors.10 Despite such compelling evidence, it remains uncertain whether reduced expression of α5GABAA receptors contributes to the behavioral symptoms of ASDs. The activity of GABAA receptors is modified by proteins that regulate the trafficking and anchoring of GABAA receptors to the plasma membrane. The anchoring of α5GABAA receptors at extrasynaptic regions of neurons is regulated by the cytosolic protein radixin.11 The role of radixin in ASDs has not been studied; however, exon deletions in the gene that encodes gephyrin, another GABAA receptor‐anchoring protein, have been linked to autism, schizophrenia, and seizures.12 Here, we studied whether deletion of the gene that encodes the α5 subunit (Gabra5−/−) in mice causes an autism‐like behavioral phenotype. We also examined exome sequencing data from 396 human subjects to determine whether rare coding variants in the GABRA5 gene or the radixin (RDX) gene were associated with autism.

Materials and Methods

Experimental animals

All experimental procedures were approved by the Animal Care Committee of the University of Toronto and were performed in accordance with guidelines of the Canadian Council on Animal Care. Gabra5 −/− mice were generated using a C57BL/6J and Sv129Ev background, as described previously.13 Male mice were used for all the behavioral assays except the measurements of ultrasonic vocalizations and pup retrieval. For these experiments, pups of both sexes were used and dams performed the pup retrieval. Age‐matched 3‐ to 5‐month‐old mice were used to study social interaction, social preference, grooming, and executive function. Ultrasonic vocalization was measured on postnatal days 6–8. In the pup retrieval assay, the dams were greater than 3 months of age and studies were performed at postnatal days 6–8. Behavioral tests that have been previously used to study autism‐like behaviors in mice were performed (Fig. 1A),14 as described in Data S1.
Figure 1

Gabra5 − mice exhibit fewer social contacts, reduced ultrasonic vocalizations, increased latency to retrieve pups, and increased self‐grooming. (A) Core features of autism and behavioral tests used to assess autism‐like deficits in mice. (B) Gabra5 − mice exhibit fewer total contacts with a conspecific during the social proximity test. Student's t‐test; WT, n = 12, Gabra5 −, n = 14; *P < 0.05. (C) Gabra5 − mice exhibit fewer nose‐to‐nose and nose‐to‐head contacts. Student's t‐test; WT, n = 12, Gabra5 −, n = 14; ***P < 0.0001. WT and Gabra5 − mice exhibit a similar number of nose‐to‐anogenital (P = 0.084), crawl over (P = 0.849), crawl under (P = 0.477), and rearing (P = 0.616) contacts. Student's t‐tests, n = 12–14. (D) In the three‐chamber social preference test, both Gabra5 − and WT mice spent a greater amount of time in the chamber with a conspecific than in the chamber with a novel object. Two‐way analysis of variance (ANOVA); effect of chamber, P < 0.05; effect of genotype, P = 0.815; effect of interaction, P = 0.882. (E) Ultrasonic vocalizations (USVs) in neonatal pups separated from the dam (WT, n = 8, Gabra5 − n = 7). The latency to emit the first USV was increased in Gabra5 − mice compared to WT mice. Student's t‐test; **P < 0.01. Gabra5 − emit fewer USVs over 4 min than WT mice. Student's t‐test; *P < 0.05. The time spent emitting USVs during the first minute of observation is reduced in Gabra5 − mice. Mann–Whitney U test; *P < 0.05. The average length of an individual USV was similar between WT and Gabra5 − mice. Student's t‐test; P = 0.274. (F) Time for dams to retrieve pups to the nest was greater in Gabra5 − mice than WT mice. Student's t‐test; WT, n = 9, Gabra5 − n = 10; *P < 0.05. (G) Gabra5 − spend more time self‐grooming than WT mice during a 10 min test period. Student's t‐ test; WT, n = 9, Gabra5 − n = 9; **P < 0.01. Data are presented as mean ± SEM.

Gabra5mice exhibit fewer social contacts, reduced ultrasonic vocalizations, increased latency to retrieve pups, and increased self‐grooming. (A) Core features of autism and behavioral tests used to assess autism‐like deficits in mice. (B) Gabra5mice exhibit fewer total contacts with a conspecific during the social proximity test. Student's t‐test; WT, n = 12, Gabra5 −, n = 14; *P < 0.05. (C) Gabra5mice exhibit fewer nose‐to‐nose and nose‐to‐head contacts. Student's t‐test; WT, n = 12, Gabra5 −, n = 14; ***P < 0.0001. WT and Gabra5mice exhibit a similar number of nose‐to‐anogenital (P = 0.084), crawl over (P = 0.849), crawl under (P = 0.477), and rearing (P = 0.616) contacts. Student's t‐tests, n = 12–14. (D) In the three‐chamber social preference test, both Gabra5 − and WT mice spent a greater amount of time in the chamber with a conspecific than in the chamber with a novel object. Two‐way analysis of variance (ANOVA); effect of chamber, P < 0.05; effect of genotype, P = 0.815; effect of interaction, P = 0.882. (E) Ultrasonic vocalizations (USVs) in neonatal pups separated from the dam (WT, n = 8, Gabra5 − n = 7). The latency to emit the first USV was increased in Gabra5mice compared to WT mice. Student's t‐test; **P < 0.01. Gabra5 − emit fewer USVs over 4 min than WT mice. Student's t‐test; *P < 0.05. The time spent emitting USVs during the first minute of observation is reduced in Gabra5mice. Mann–Whitney U test; *P < 0.05. The average length of an individual USV was similar between WT and Gabra5mice. Student's t‐test; P = 0.274. (F) Time for dams to retrieve pups to the nest was greater in Gabra5mice than WT mice. Student's t‐test; WT, n = 9, Gabra5 − n = 10; *P < 0.05. (G) Gabra5 − spend more time self‐grooming than WT mice during a 10 min test period. Student's t‐ test; WT, n = 9, Gabra5 − n = 9; **P < 0.01. Data are presented as mean ± SEM.

Exome data from human probands

The coding sequences of GABRA5 (on human chromosome 15) and RDX (on chromosome 11) were examined for coding sequence variants. Next‐generation exome sequencing data from 396 Canadian ASD probands was used to detect potential sequence variants, as previously described12 (see also Data S1). All subjects and/or parents consented to the study, which was approved by the Research Ethics Board of the Hospital for Sick Children. Following a general protocol that was similar to those used in previous studies,4 rare variants were defined as those with a frequency of less than 1% in population databases (The 1000 Genomes Project, NHLBI Exome Sequencing Project and the Exome Aggregation Consortium).15 All novel or rare nonsynonymous variants were validated using Sanger sequencing. Damaging missense single‐nucleotide variants were defined as those predicted to be functionally damaging by SIFT and PolyPhen‐2 prediction software.

Results

Reduced social contact is a common behavioral feature of ASDs. To study social contact, the social proximity assay was used to measure interactions between a test mouse and a conspecific.16 Gabra5mice exhibited significantly fewer social contacts than wild‐type (WT) mice (t (24) = 2.28, P = 0.031 Fig. 1B). The numbers of nose‐to‐nose (t (24) = 4.68, P < 0.0001) and nose‐to‐head (t (24) = 4.14, P < 0.001) contacts were reduced in Gabra5mice. Other forms of social contact were similar between the genotypes (Fig. 1C). Next, preference for social stimuli was assessed using the three‐chamber social approach test.17 During the habituation phase of the study, WT and Gabra5mice spent equal time in the left and right chambers, indicating no inherent preference (genotype: F 1,72 = 0.0, P = 1.0; interaction: F 2,72 = 0.758, P = 0.472; center chamber: WT 148.0 ± 9.36 sec vs. Gabra5 − 133.58 ± 10.95 sec; left chamber: WT 364.29 ± 11.33 sec vs. Gabra5 − 372.75 ± 11.40 sec; right chamber: WT 387.71 ± 8.63 sec vs. Gabra5 − 393.67 ± 9.07 sec). During the testing phase, WT and Gabra5mice spent more time in the chamber that contained the conspecific. Thus, both genotypes exhibited a normal social preference in this test (chamber: F 2,72 = 34.85, P < 0.0001; genotype: F 1,72 = 0.02, P = 0.815; interaction: F 2,72 = 0.33, P = 0.716; Fig. 1D). To assess communication, we measured ultrasonic vocalizations (USVs) that were emitted by neonatal pups that had been separated from the dam.18, 19 The latency to emit the first USV was increased in Gabra5mice relative to WTs (t (13) = 3.27, P = 0.006; Fig. 1E). The total number of calls was reduced in Gabra5mice (t (13) = 2.47, P = 0.029; Fig. 1E). In addition, the emitting time recorded during the first minute of separation was reduced in Gabra5mice compared to WT mice, demonstrating a reduction in vocalization (Mann–Whitney U = 10.0, P = 0.04; Fig. 1E). The average length of individual USVs was no different between groups (t (13) = 1.14, P = 0.274; Fig. 1E). To determine whether there were functional implications of the reduced USVs, the time required for the dams to retrieve five pups to the nest following the 3‐min separation period was measured. The latency to retrieval was increased in Gabra5 − dams relative to WT dams (t (17) = 2.49, P = 0.024; Fig. 1F). Next, repetitive behaviors, which are a common feature of ASDs, were studied. Such unusually long periods of self‐grooming in mice are considered to be a spontaneous form of motor stereotypy.20 Gabra5mice spent more time self‐grooming than WT mice during a 10‐min observation period (t (16) = 3.25, P = 0.005; Fig. 1G). Executive function, which refers to problem solving and cognitive flexibility, is often impaired in ASDs.21 Executive function was assessed with the puzzle box. In this assay, mice were presented with progressively more difficult tasks to reach the goal (darkened) box (Fig. 2A).22 Relative to WT mice, Gabra5mice required more time to reach the goal box and thus exhibited impaired performance on the first exposure to a new challenge that required burrowing (Tukey's post hoc P < 0.05) and for the removal of a plug that obstructed the underpass (post hoc test P < 0.001, genotype F 1,68 = 20.31, P < 0.0001; interaction F 3,68 = 6.56, P < 0.001; Fig. 2B). Short‐term memory, an important element of executive function, was assessed by retesting the mice 2 min after the first exposure to the task. Latency for the plug task was longer in Gabra5mice (genotype F 1,51 = 9.91, P = 0.003; interaction F 2,51 = 5.75, P = 0.006; post hoc test P < 0.001; Fig. 2C). Long‐term memory tested 24 h after the first exposure to both the underpass and burrowing tasks was not impaired in Gabra5mice (Fig. 2D).
Figure 2

Executive function is impaired in Gabra5 − mice. (A) Schematic of the puzzle box test. (B) Gabra5 − mice and WT mice exhibited a similar latency at baseline, to enter the goal box through the open door and a similar latency on day 1, when they were required to use the underpass to enter the goal box. Gabra5 − exhibited a longer latency than WT mice to burrow through bedding on day 2, or remove a cardboard plug on day 3 to gain access to the goal box. Two‐way analysis of variance (ANOVA); n = 9–10; effect of genotype, P < 0.0001; effect of trial, P < 0.0001; effect of interaction, P < 0.001. Tukey's HSD post hoc test; *P < 0.05, ***P < 0.001. (C) Short‐term memory (STM) on the puzzle box test, tested 2 min after first exposure to the task. Gabra5 − mice exhibit impaired short‐term memory and a longer latency to complete the short‐term memory plug task. Two‐way analysis of variance (ANOVA); n = 9–10; effect of genotype, P < 0.01; effect of trial, P < 0.0001; effect of interaction, P < 0.05; Tukey's HSD post hoc test, **P < 0.001. (D) Long‐term memory (LTM) on the puzzle box test, tested 24 h after first exposure to the task. Gabra5 − and WT mice exhibit similar performance on the underpass and burrowing long‐term memory tasks. Two‐way analysis of variance (ANOVA); n = 9–10; effect of genotype, P = 0.238; effect of trial, P < 0.01; effect of interaction, P = 0.979. (E–G) Performance of WT and Gabra5 − mice in the open‐field test. (E) Gabra5 − and WT mice exhibited a similar distance travelled in the open‐field test over a 30‐min test period. Gabra5 − and WT mice spent a similar amount of time in the center (F) and perimeter (G) regions of the open field. Student's t‐test; n = 10. Data are presented as mean ± SEM.

Executive function is impaired in Gabra5mice. (A) Schematic of the puzzle box test. (B) Gabra5mice and WT mice exhibited a similar latency at baseline, to enter the goal box through the open door and a similar latency on day 1, when they were required to use the underpass to enter the goal box. Gabra5 − exhibited a longer latency than WT mice to burrow through bedding on day 2, or remove a cardboard plug on day 3 to gain access to the goal box. Two‐way analysis of variance (ANOVA); n = 9–10; effect of genotype, P < 0.0001; effect of trial, P < 0.0001; effect of interaction, P < 0.001. Tukey's HSD post hoc test; *P < 0.05, ***P < 0.001. (C) Short‐term memory (STM) on the puzzle box test, tested 2 min after first exposure to the task. Gabra5mice exhibit impaired short‐term memory and a longer latency to complete the short‐term memory plug task. Two‐way analysis of variance (ANOVA); n = 9–10; effect of genotype, P < 0.01; effect of trial, P < 0.0001; effect of interaction, P < 0.05; Tukey's HSD post hoc test, **P < 0.001. (D) Long‐term memory (LTM) on the puzzle box test, tested 24 h after first exposure to the task. Gabra5 − and WT mice exhibit similar performance on the underpass and burrowing long‐term memory tasks. Two‐way analysis of variance (ANOVA); n = 9–10; effect of genotype, P = 0.238; effect of trial, P < 0.01; effect of interaction, P = 0.979. (E–G) Performance of WT and Gabra5mice in the open‐field test. (E) Gabra5 − and WT mice exhibited a similar distance travelled in the open‐field test over a 30‐min test period. Gabra5 − and WT mice spent a similar amount of time in the center (F) and perimeter (G) regions of the open field. Student's t‐test; n = 10. Data are presented as mean ± SEM. In the open‐field test, no differences were observed between WT and Gabra5mice (Fig. 2E–G) suggesting normal locomotion and anxiety in Gabra5mice.

Mutations in GABRA5 and RDX in ASD probands

De novo and rare inherited sequence‐level variants have been shown to contribute to ASD risk.21, 23 Consequently, the coding sequences of GABRA5 and RDX were screened for coding sequence variation using next‐generation exome sequencing data from a cohort of 396 Canadian ASD probands. Two rare missense coding variants were identified in GABRA5, each in a single male ASD case. One of the variants was predicted to be functionally damaging as indicated by both PolyPhen‐2 and SIFT prediction software (Table 1). Four missense coding variants were identified in RDX. One of the variants (hg 19 chr11:110,104,062) was present in three male probands, whereas the remaining variants were present in single ASD cases, two male and one female. Two of the variants in RDX were predicted to be functionally damaging.
Table 1

Missense mutations in Gabra5 and Rdx in ASD probands

GenePositionProbandCodon changeSubstitutionInheritancePolyPhen‐2 predictionSIFT prediction
GABRA5 chr15:27,182,3611MGtc/AtcV204IMaternal0.005 benign0.41 tolerated
GABRA5 chr15:27,128,5451MgGg/gCgG113AMaternal0.991 probably damaging0.04 damaging
RDX chr11:110,104,0021MaCc/aTcT516IPaternal0.998 probably damaging0.02 damaging
RDX chr11:110,104,1381MCct/ActP471TMaternal0.585 possibly damaging0.51 tolerated
RDX chr11:110,128,6011FGat/CatD197HHeterozygous in both0.999 probably damaging0.0 damaging
RDX chr11:110,104,0623MgCt/gTtA496V 1 Paternal 2 Maternal 0.999 probably damaging0.52 tolerated

The position of the mutation, the sex of the proband (M, male; F, female), the specific codon change, the resultant amino acid substitution, and the inheritance (maternal, paternal, or both) are listed. The prediction scores generated by PolyPhen‐2 and SIFT software are listed for each mutation. A PolyPhen‐2 score <0.5 denotes a mutation that is predicted to be benign, a score >0.5 denotes a mutation that is probably damaging, and a score = 1 denotes a mutation that is predicted to be damaging. A SIFT score <0.05 denotes a damaging mutation and a score >0.05 denotes a tolerated mutation.

Missense mutations in Gabra5 and Rdx in ASD probands The position of the mutation, the sex of the proband (M, male; F, female), the specific codon change, the resultant amino acid substitution, and the inheritance (maternal, paternal, or both) are listed. The prediction scores generated by PolyPhen‐2 and SIFT software are listed for each mutation. A PolyPhen‐2 score <0.5 denotes a mutation that is predicted to be benign, a score >0.5 denotes a mutation that is probably damaging, and a score = 1 denotes a mutation that is predicted to be damaging. A SIFT score <0.05 denotes a damaging mutation and a score >0.05 denotes a tolerated mutation.

Discussion

Global deletion of the Gabra5 gene causes autism‐like behaviors that are similar to those observed in other ASD mouse models, including the Tuberous sclerosis 1 mouse, the Shank1 null‐mutant mouse, and inbred BTBR T+tf/J mice.16, 18, 19, 20 Having identified a behavioral phenotype in Gabra5mice, we sought to determine whether pathogenic variants in GABRA5 or RDX might be found in human subjects with ASD. From a cohort of 396 cases analyzed by exome sequencing, we identified six rare missense variants (<1% frequency in population databases). Three of these missense mutations were predicted to damage protein function. RDX encodes the anchoring protein radixin and damaging coding variants are predicted to decrease the number of α5GABAA receptors at extrasynaptic sites. Although rare missense coding variants of RDX have not been previously reported in ASD cases, exonic deletions of the GABAA receptor‐anchoring protein gephyrin have been associated with psychiatric conditions, including autism.12 It remains to be determined whether the variants identified in this study contribute to ASD cases. Individuals with autism frequently exhibit problems with learning and memory. Results from this study showed that Gabra5mice exhibit deficits in short‐term memory but only when the task became increasingly more difficult (i.e., the plug task). In contrast, no long‐term memory deficits were observed in the Gabra5mice. These experimental results are consistent with previous reports that show deficits depend on cognitive domain and demand of the task. For example, memory performance of Gabra5mice is unimpaired for contextual fear memory, cued fear conditioning and novel object recognition.24, 25 However, selective knockdown of Gabra5 in the dentate gyrus of the hippocampus caused impaired performance when mice were required to distinguish between an aversive context and a similar safe context.26 Reversal learning in the Morris Water Maze task was also impaired in these mice.26 Interestingly, Gabra5mice show improved performance for trace fear conditioning and the Morris water maze compared with WT mice.13, 24 Thus, only certain learning and memory tasks are vulnerable to reduced expression levels of α5GABAA receptors. The role of α5GABAA receptors in memory formation is further supported by previous studies of long‐term potentiation (LTP) of excitatory synaptic transmission in the hippocampus.24 LTP is widely considered to be a network substrate of memory and α5GABAA receptors set the level of stimulation that is required to induce LTP in the CA1 subfield of the hippocampus.24 Specifically, stimulation of Schaffer collaterals at a low frequency (10 Hz) elicits long‐term depression of excitatory transmission in slices from wild‐type mice, whereas the same level of stimulation elicits LTP in Gabra5 − slices. Thus, α5GABAA receptors set the threshold for stimulating LTP and may therefore be involved in memory formation.24 Consistent with the above findings, a current theory suggests that autism‐like behaviors result from an increase in the ratio of excitatory to inhibitory neurotransmission (E/I) in the brain.27 The autism‐like behaviors observed in Gabra5mice may result from an increased E/I ratio. Indeed, Gabra5mice exhibit a reduced tonic inhibitory conductance and increased excitability of principal neurons in the hippocampus.28 In other brain regions, this increase in neuronal excitability may lead to autism‐like behavioral deficits. Even transient depolarization of neurons using optogenetic techniques in the medial prefrontal cortex causes deficits in social behavior, and concomitant photostimulation of inhibitory, GABAergic neurons partially reverses these deficits.29 Similarly, treatment with a drug that increases GABAA receptor function reverses abnormal social behavior in the Scn1a+/− mouse model of autism.30 The results from the current study suggest that drugs that act as positive allosteric modulators of α5GABAA receptors may ameliorate autism‐like behaviors.31, 32 Certain positive allosteric modulators that reverse deficits in spatial memory in aged rats and locomotor hyperactivity in a mouse model of schizophrenia may reduce autism‐like behavioral deficits.31, 32 Finally, reduced expression and function of GABRA5 and RDX may cause neurodevelopmental changes that contribute to ASD‐like behavior. In future studies, it will be of interest to determine whether clinical disorders (e.g., seizures or cognitive defects) are observed in individuals with mutations of GABRA5 or RDX genes. Such an association would further strengthen the E/I hypothesis of autism. In summary, our results show that reduced expression of α5GABAA receptors contributes to autism‐like behaviors in mice and potentially damaging mutations of GABRA5 and RDX occur in ASD cases.

Author Contributions

A. A. Z. conceived and designed the study, acquired and analyzed the data, and drafted the manuscript and figures. S. W. P. K. acquired and analyzed the data and contributed to the drafting of the manuscript. Z. A. acquired and analyzed the data. S. W. acquired and analyzed the data and contributed to the drafting of the manuscript. M. M., A. J. M., and E. S. contributed to the study design and drafting of the manuscript. S. W. S. contributed to the study design, data, and drafting of the manuscript. B. A. O. contributed to the study design and drafting of the manuscript and figures.

Conflict of Interest

None declared. Data S1. Detailed Methods Click here for additional data file.
  32 in total

1.  The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia.

Authors:  Nada M-B Ben Abdallah; Johannes Fuss; Massimo Trusel; Michael J Galsworthy; Kristin Bobsin; Giovanni Colacicco; Robert M J Deacon; Marco A Riva; Christoph Kellendonk; Rolf Sprengel; Hans-Peter Lipp; Peter Gass
Journal:  Exp Neurol       Date:  2010-09-17       Impact factor: 5.330

Review 2.  Behavioural phenotyping assays for mouse models of autism.

Authors:  Jill L Silverman; Mu Yang; Catherine Lord; Jacqueline N Crawley
Journal:  Nat Rev Neurosci       Date:  2010-07       Impact factor: 34.870

3.  Alpha5GABAA receptors regulate the intrinsic excitability of mouse hippocampal pyramidal neurons.

Authors:  Robert P Bonin; Loren J Martin; John F MacDonald; Beverley A Orser
Journal:  J Neurophysiol       Date:  2007-08-22       Impact factor: 2.714

4.  Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures.

Authors:  Anath C Lionel; Andrea K Vaags; Daisuke Sato; Matthew J Gazzellone; Elyse B Mitchell; Hong Yang Chen; Gregory Costain; Susan Walker; Gerald Egger; Bhooma Thiruvahindrapuram; Daniele Merico; Aparna Prasad; Evdokia Anagnostou; Eric Fombonne; Lonnie Zwaigenbaum; Wendy Roberts; Peter Szatmari; Bridget A Fernandez; Lyudmila Georgieva; Linda M Brzustowicz; Katharina Roetzer; Wolfgang Kaschnitz; John B Vincent; Christian Windpassinger; Christian R Marshall; Rosario R Trifiletti; Salman Kirmani; George Kirov; Erwin Petek; Jennelle C Hodge; Anne S Bassett; Stephen W Scherer
Journal:  Hum Mol Genet       Date:  2013-02-07       Impact factor: 6.150

Review 5.  Model of autism: increased ratio of excitation/inhibition in key neural systems.

Authors:  J L R Rubenstein; M M Merzenich
Journal:  Genes Brain Behav       Date:  2003-10       Impact factor: 3.449

6.  Activated radixin is essential for GABAA receptor alpha5 subunit anchoring at the actin cytoskeleton.

Authors:  Sven Loebrich; Robert Bähring; Tatsuya Katsuno; Sachiko Tsukita; Matthias Kneussel
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

7.  The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study.

Authors:  Maria Andreina Mendez; Jamie Horder; Jim Myers; Suzanne Coghlan; Paul Stokes; David Erritzoe; Oliver Howes; Anne Lingford-Hughes; Declan Murphy; David Nutt
Journal:  Neuropharmacology       Date:  2012-04-21       Impact factor: 5.250

8.  Tonic Inhibitory Control of Dentate Gyrus Granule Cells by α5-Containing GABAA Receptors Reduces Memory Interference.

Authors:  Elif Engin; Ewa D Zarnowska; Dietmar Benke; Evgeny Tsvetkov; Maksim Sigal; Ruth Keist; Vadim Y Bolshakov; Robert A Pearce; Uwe Rudolph
Journal:  J Neurosci       Date:  2015-10-07       Impact factor: 6.167

9.  Synaptic, transcriptional and chromatin genes disrupted in autism.

Authors:  Silvia De Rubeis; Xin He; Arthur P Goldberg; Christopher S Poultney; Kaitlin Samocha; A Erucment Cicek; Yan Kou; Li Liu; Menachem Fromer; Susan Walker; Tarinder Singh; Lambertus Klei; Jack Kosmicki; Fu Shih-Chen; Branko Aleksic; Monica Biscaldi; Patrick F Bolton; Jessica M Brownfeld; Jinlu Cai; Nicholas G Campbell; Angel Carracedo; Maria H Chahrour; Andreas G Chiocchetti; Hilary Coon; Emily L Crawford; Sarah R Curran; Geraldine Dawson; Eftichia Duketis; Bridget A Fernandez; Louise Gallagher; Evan Geller; Stephen J Guter; R Sean Hill; Juliana Ionita-Laza; Patricia Jimenz Gonzalez; Helena Kilpinen; Sabine M Klauck; Alexander Kolevzon; Irene Lee; Irene Lei; Jing Lei; Terho Lehtimäki; Chiao-Feng Lin; Avi Ma'ayan; Christian R Marshall; Alison L McInnes; Benjamin Neale; Michael J Owen; Noriio Ozaki; Mara Parellada; Jeremy R Parr; Shaun Purcell; Kaija Puura; Deepthi Rajagopalan; Karola Rehnström; Abraham Reichenberg; Aniko Sabo; Michael Sachse; Stephan J Sanders; Chad Schafer; Martin Schulte-Rüther; David Skuse; Christine Stevens; Peter Szatmari; Kristiina Tammimies; Otto Valladares; Annette Voran; Wang Li-San; Lauren A Weiss; A Jeremy Willsey; Timothy W Yu; Ryan K C Yuen; Edwin H Cook; Christine M Freitag; Michael Gill; Christina M Hultman; Thomas Lehner; Aaarno Palotie; Gerard D Schellenberg; Pamela Sklar; Matthew W State; James S Sutcliffe; Christiopher A Walsh; Stephen W Scherer; Michael E Zwick; Jeffrey C Barett; David J Cutler; Kathryn Roeder; Bernie Devlin; Mark J Daly; Joseph D Buxbaum
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

10.  Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission.

Authors:  Sung Han; Chao Tai; Ruth E Westenbroek; Frank H Yu; Christine S Cheah; Gregory B Potter; John L Rubenstein; Todd Scheuer; Horacio O de la Iglesia; William A Catterall
Journal:  Nature       Date:  2012-08-22       Impact factor: 49.962

View more
  18 in total

Review 1.  Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders.

Authors:  Thomas Prévot; Etienne Sibille
Journal:  Mol Psychiatry       Date:  2020-04-28       Impact factor: 15.992

2.  Chronic maternal interleukin-17 and autism-related cortical gene expression, neurobiology, and behavior.

Authors:  Serena Banu Gumusoglu; Benjamin Wen Qing Hing; Akanksha Sri Satya Chilukuri; Jessica Jolynn Dewitt; Sabrina Marie Scroggins; Hanna Elizabeth Stevens
Journal:  Neuropsychopharmacology       Date:  2020-02-19       Impact factor: 7.853

Review 3.  Memory suppressor genes: Modulating acquisition, consolidation, and forgetting.

Authors:  Nathaniel C Noyes; Anna Phan; Ronald L Davis
Journal:  Neuron       Date:  2021-08-26       Impact factor: 18.688

4.  Shisa7 phosphorylation regulates GABAergic transmission and neurodevelopmental behaviors.

Authors:  Kunwei Wu; Ryan David Shepard; David Castellano; Wenyan Han; Qingjun Tian; Lijin Dong; Wei Lu
Journal:  Neuropsychopharmacology       Date:  2022-05-09       Impact factor: 8.294

5.  Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.

Authors:  Ciria C Hernandez; Wenshu XiangWei; Ningning Hu; Dingding Shen; Wangzhen Shen; Andre H Lagrange; Yujia Zhang; Lifang Dai; Changhong Ding; Zhaohui Sun; Jiasheng Hu; Hongmin Zhu; Yuwu Jiang; Robert L Macdonald
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

6.  Sepsis-induced selective loss of NMDA receptors modulates hippocampal neuropathology in surviving septic mice.

Authors:  Shuibing Zhang; Xueqin Wang; Sha Ai; Wen Ouyang; Yuan Le; Jianbin Tong
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

7.  Pre-existing weakness is critical for the occurrence of postoperative cognitive dysfunction in mice of the same age.

Authors:  Yujie Tang; Xueqin Wang; Shuibing Zhang; Shangchun Duan; Wenxiang Qing; Gong Chen; Feng Ye; Yuan Le; Wen Ouyang
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

8.  GABAA receptor subunit gene polymorphisms predict symptom-based and developmental deficits in Chinese Han children and adolescents with autistic spectrum disorders.

Authors:  Shuhan Yang; Xuan Guo; Xiaopeng Dong; Yu Han; Lei Gao; Yuanyuan Su; Wei Dai; Xin Zhang
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

Review 9.  Disinhibition, an emerging pharmacology of learning and memory.

Authors:  Hanns Möhler; Uwe Rudolph
Journal:  F1000Res       Date:  2017-02-03

10.  Sustained treatment with an α5 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission.

Authors:  Jessica L Nuwer; Megan L Brady; Nadya V Povysheva; Amanda Coyne; Tija C Jacob
Journal:  Neuropharmacology       Date:  2021-07-17       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.